News
Inspire Beats Q2 Estimates Despite 7.6% Revenue Dip, Raises Full-Year Guidance
Inspire Medical Systems topped Q2 expectations on both the top and bottom lines, nudging up its full-year outlook. Shares jumped as much as 13.6% after the print.
From opening an account to options — US stocks and financial markets explained simply and clearly. Every topic comes with authoritative sources, a table of contents, and an FAQ: a beginner-friendly knowledge base built for investors.